Confronto
Pemvidutide vs. Pramlintid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Metabolico
Metabolico
N. CAS
nessun dato
151126-32-8
Peso molecolare
nessun dato
3949.4 g/mol
Emivita
nessun dato
nessun dato
Sequenza
nessun dato
nessun dato
Meccanismo d'azione
Pemvidutide
The GLP-1 component suppresses appetite while the glucagon component raises energy expenditure and acts directly on hepatic fat metabolism — the combination is intended to mimic the complementary effects of diet and exercise.
Pramlintid
Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.
Base di evidenze
Evidenza più alta
Studio sull'uomo
RCT sull'uomo
Studi
1
0
di cui sull'uomo
1
0
Effetti registrati
2
2
Contraddizioni aperte
0
1
Eventi avversi documentati
1
2
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Pemvidutide and Pramlintid?
- Pemvidutide is classified as "Metabolico", while Pramlintid is classified as "Metabolico". Pemvidutide: Pemvidutide is a 29-amino-acid GLP-1/glucagon dual receptor agonist (Altimmune) under investigation for obesity and the fatty-liver disease MASH. Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Pemvidutide or Pramlintid?
- The highest available evidence level is "Studio sull'uomo" for Pemvidutide and "RCT sull'uomo" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Pemvidutide and Pramlintid in Germany and the United States?
- Germania: Pemvidutide — Non approvato, Pramlintid — Non approvato. Stati Uniti: Pemvidutide — Non approvato, Pramlintid — Su prescrizione. These are factual summaries with source and review date on the individual pages.